We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioInvent and ThromboGenics Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer

News   Jan 21, 2008

 
BioInvent and ThromboGenics Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
 
 
 

RELATED ARTICLES

Biopatch Delivers Exact Drug Doses Directly into Cells

News

Minimally invasive patch developed by Purdue researchers delivers exact doses directly into cells, lessens pain and toxicity.

READ MORE


Stroke of Genius: Drug Could Target Leading Cause in Young

News

A study led by researchers at the Centenary Institute has identified a drug currently used to treat cancer patients, as a potential treatment option for a leading cause of stroke in young people.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE